Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Mullan Pharmaceutical Inc., priced at $0.0247 per EA under NDC 83301000901. Its NADAC has been published 46 times since Aug 13, 2025.
Strength
850 mg/1
Manufacturer
Mullan Pharmaceutical Inc.NDC
83301000901
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205096On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 46 times since Aug 13, 2025, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0247 per EA |
|---|---|
| All-time high | $0.0248 (Jun 10, 2026) |
| All-time low | $0.0224 (Sep 17, 2025) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0236 |
| Average price | $0.0236 |
| Largest weekly change | +2.7% (Dec 17, 2025) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Mullan Pharmaceutical Inc., is $0.0247 per EA (NDC 83301000901), effective Jun 24, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has risen 6.8%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Aug 13, 2025, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0224 (Sep 17, 2025) to a high of $0.0248 (Jun 10, 2026), with a median of $0.0236 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as METFORMIN HCL 850 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 83301000901) is labeled by Mullan Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification